486
Participants
Start Date
July 31, 2007
Primary Completion Date
April 30, 2013
Study Completion Date
December 31, 2016
cediranib
Once-daily oral tablet starting dose 20mg
University College London, London
Lead Sponsor
Collaborators (3)
Cancer Research UK
OTHER
National Health and Medical Research Council, Australia
OTHER
Australia New Zealand Gynaecological Oncology Group
OTHER
NCIC Clinical Trials Group
NETWORK
Grupo Español de Investigación en Cáncer de Ovario
OTHER
AstraZeneca
INDUSTRY
Medical Research Council
OTHER_GOV